Literature DB >> 18466419

Use of antihypertensive drugs during pregnancy and lactation.

Firas A Ghanem1, Assad Movahed.   

Abstract

The decision to treat elevated arterial pressure in pregnancy depends on the risk and benefits imposed on the mother and the fetus. Treatment for mild-to-moderate hypertension during pregnancy may not reduce maternal or fetal risk. Severe hypertension, on the other hand, should be treated to decrease maternal risk. Methyldopa and beta-adrenoceptor antagonists have been used most extensively. In acute severe hypertension, intravenous labetalol or oral nifedipine are reasonable choices.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18466419     DOI: 10.1111/j.1527-3466.2007.00036.x

Source DB:  PubMed          Journal:  Cardiovasc Ther        ISSN: 1755-5914            Impact factor:   3.023


  13 in total

1.  Cardiοvascular diseases in pregnancy.

Authors:  Dimitrios Godosis; Spyridon Komaitis; Konstantinos Tziomalos; Maria Baltatzi; Georgios Ntaios; Christos G Savopoulos; Apostolos I Hatzitolios
Journal:  Am J Cardiovasc Dis       Date:  2012-05-15

Review 2.  Adverse pregnancy outcomes and cardiovascular risk factor management.

Authors:  Puja K Mehta; Margo Minissian; C Noel Bairey Merz
Journal:  Semin Perinatol       Date:  2015-07-06       Impact factor: 3.300

Review 3.  Treating Hypertension in Pregnancy.

Authors:  Dietmar Schlembach; Volker Homuth; Ralf Dechend
Journal:  Curr Hypertens Rep       Date:  2015-08       Impact factor: 5.369

Review 4.  Drugs for treating severe hypertension in pregnancy: a network meta-analysis and trial sequential analysis of randomized clinical trials.

Authors:  Kannan Sridharan; Reginald P Sequeira
Journal:  Br J Clin Pharmacol       Date:  2018-07-08       Impact factor: 4.335

5.  Fetal safety of calcium channel blockers.

Authors:  Fatoumah Alabdulrazzaq; Gideon Koren
Journal:  Can Fam Physician       Date:  2012-07       Impact factor: 3.275

Review 6.  Hypertension in the postpartum woman: clinical update for the hypertension specialist.

Authors:  Nimrta Ghuman; Jacqueline Rheiner; Beatriz E Tendler; William B White
Journal:  J Clin Hypertens (Greenwich)       Date:  2009-12       Impact factor: 3.738

Review 7.  Regulators of G protein signaling in cardiovascular function during pregnancy.

Authors:  Katherine J Perschbacher; Guorui Deng; Rory A Fisher; Katherine N Gibson-Corley; Mark K Santillan; Justin L Grobe
Journal:  Physiol Genomics       Date:  2018-04-27       Impact factor: 3.107

8.  Independent Determinants of Maternal and Fetal Outcomes in a Sample of Pregnant Outpatients With Normal Blood Pressure, Chronic Hypertension, Gestational Hypertension, and Preeclampsia.

Authors:  Arrigo F G Cicero; Daniela Degli Esposti; Vincenzo Immordino; Martino Morbini; Cristina Baronio; Martina Rosticci; Claudio Borghi
Journal:  J Clin Hypertens (Greenwich)       Date:  2015-07-14       Impact factor: 3.738

9.  Early pharmacological inhibition of angiotensin-I converting enzyme activity induces obesity in adulthood.

Authors:  Kely de Picoli Souza; Elton D da Silva; Elice C Batista; Felipe C G Reis; Sylvia M A Silva; Charlles H M Castro; Jaqueline Luz; Jorge L Pesquero; Edson L Dos Santos; João B Pesquero
Journal:  Front Pharmacol       Date:  2015-04-14       Impact factor: 5.810

10.  Pregnancy in a patient with cancer and heart failure: challenges and complexities.

Authors:  Anecita P Fadol; Tara Lech; Courtney Bickford; Syed Wamique Yusuf
Journal:  J Adv Pract Oncol       Date:  2012-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.